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ABSTRACT
Background: Some polyphenols possess anti-allergic activities. Naringenin chalcone is one of the polyphe-
nols that is present in the skin of red tomatoes. In this study, we investigated the effect of naringenin chalcone
in allergic responses in vivo using an experimental mouse model system of allergic asthma.
Methods: Allergic airway inflammation was induced in mice by sensitization and challenge with ovalbumin.
Naringenin chalcone was orally administrated every day during the course of the experiment. Airway hyperre-
activity, the eosinophilic infiltration in the bronchioalveolar lavage fluid and Th2 cytokine production from
splenic CD4 T cells were assessed.
Results: Eosinophilic airway inflammation, airway hyperreactivity and Th2 cytokine production from CD4 T
cells were significantly suppressed in mice that were treated with naringenin chalcone. Hyperproduction of mu-
cus was slightly reduced.
Conclusions: The results of this study suggest that naringenin chalcone suppresses asthmatic symptoms by
inhibiting Th2 cytokine production from CD4 T cells. Thus, naringenin chalcone may be a useful supplement for
the suppression of allergic symptoms in humans.
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INTRODUCTION
The number of allergic patients has increased in de-
veloped countries.1 Asthma is a chronic inflammatory
disease of the lower airways that causes airway hy-
perreactivity (AHR) to a wide variety of specific and
non-specific stimuli.2 In most cases, the strength of
AHR correlates with the level of airway inflammation,
another hallmark of asthma, which is characterized
by eosinophil infiltration, mucus hyperproduction,
production of Th2 cytokines (IL-4, -5 and -13) and
allergen-specific IgE.3-5
Th2 cells that produce these cytokines play an im-
portant role in allergic asthma.6 IL-4 and IL-13 pro-
duced from Th2 cells initiate the synthesis of antigen-
specific IgE from B cells. IgE antibodies circulate in
the blood and bind to high affinity IgE receptors
(FcεRI) on the surface of mast cells. When allergens
are bound to the receptor-bound IgE molecules, mast
cells become activated and release cytokines,
chemokines, and chemical mediators, such as hista-
mine, prostaglandin, and leukotrienes, which induce
airway smooth-muscle contraction and increased vas-
cular permeability.6,7 In the epithelial cells, IL-4 and
IL-13 can induce goblet cell hyperplasia.8
Topical corticosteroids and topical immunosup-
pressants are commonly used for the treatment of al-
lergic diseases. However, these drugs strongly in-
hibit the immune system, and sometimes induce sev-
eral side effects, particularly when they are used for
extended periods. Therefore, substitutes for steroids
are still required. Some polyphenols possess anti-
allergic activities.9-13 Tomatoes are a popular vegeta-
ble that are produced almost all over the world. To-
matoes contain many polyphenols, such as chloro-
genic acid and rutin. Naringenin chalcone (NGC) is
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one of the polyphenols that is present in the skin of
red tomatoes.10 Therefore, we investigated whether
the in vivo administration of NGC induces any sup-
pressive activities on allergic reactions, using a popu-
lar experimental mouse model system of allergic
asthma.
METHODS
ANIMALS
BALBc mice were purchased from Clea Inc., Tokyo,
Japan. The mice used in this study were 6 to 7 weeks
of age. A total of three independent experiments were
performed for each experiment (n = 5 per group). All
of the mice used in this study were maintained under
specific pathogen free conditions. All of the animal
care was conducted in accordance with the guide-
lines of Chiba University.
SAMPLE PREPARATION FROM THE TOMATO
SKIN EXTRACT
The tomato (Lycopersicon esculentum Miller) skin ex-
tract containing polyphenols was prepared by incu-
bating a mixture of tomato skin with 60% (vv) etha-
nol at 60℃ for 2 hours, followed by lyophilization.
The extract contained approximately 0.2% naringenin
chalcone (NGC). NGC was separated from the to-
mato skin extract by a HPLC method using a Capcell
Pak C18 column (250 mm × 15 mm I.D.; Shiseido, To-
kyo, Japan). The elution was carried out with acetoni-
trilewater (33 : 67, vv) mixture containing 0.1%
trifluoroacetic acid at a flow rate of 5 mLminute, at
room temperature with the instrument’s wavelength
set at 350 nm for the monitoring of the eluant. The
peak fraction was collected, concentrated under re-
duced pressure to remove the organic solvents, and
then freeze-dried. The purity of NGC was >98 %.
INDUCTION OF ALLERGIC ASTHMA AND THE
ADMINISTRATION OF NARINGENIN CHALCONE
The mice were sensitized by intraperitoneal injection
of 100 μg Ovalbumin (OVA: SIGMA-Aldrich, St.
Louis, USA) adsorbed to 1 mg alum (PIERCE, Rock-
ford, USA) on day 0 and day 7. The mice were then
challenged with aerosolized OVA in saline (10 mg
mL) by inhalation for 30 minutes using a supersonic
nebulizer (model NE-U07; Omuron Co., Tokyo, Ja-
pan) on day 21 and 23. NGC (0.8 mgkg) was orally
administered in a 0.5% carboxymethyl cellulose so-
dium salt solution (5 mLkg of body weight) every
day during the entire course of the experiments. A
0.5% carboxymethyl cellulose sodium salt solution
without NGC was administrated as a placebo. The
half-life of the metabolites of NCG in the blood of rat
receiving the equivalent amount of NCG was 5.5 ± 1.7
hours,14 and about 60% of the NCG appeared to be ab-
sorbed.
MEASUREMENT OF AIRWAY HYPERREACTIV-
ITY (AHR)
The AHR was assessed by methacholine-induced air-
flow obstruction 24 hours after the last antigen chal-
lenge as previously described.15 The respiratory pa-
rameters were obtained by exposure of the mice to
0.9% saline mist, followed by incremental doses of
aerosolized methacholine (0, 12, 24, 48 mgmL in a
saline solution). The AHR was assessed by a com-
puter-controlled small animal ventilator (SCIREQ,
Montreal, Canada).
COLLECTION OF THE BRONCHIOALVEOLAR
LAVAGE FLUID
Bronchioalveolar lavage (BAL) was performed 24
hours after the last OVA challenge as described pre-
viously.16 All the BAL fluid was collected and the cells
were counted in the 100-μl aliquots. A total of 1 × 105
viable BAL cells were cytocentrifuged onto slides by
a Cytospin4 (Thermo Electron, Waltham, USA) and
stained with May-Grunwald-Giemza solution (MERCK,
Darmstadt, Germany). A total of 500 leukocytes were
counted for each slide. The cell types were identified
using morphological criteria. The percentages of
each cell type were calculated.
MEASUREMENT OF THE ANTIBODY TITER IN
SERUM
The concentration of OVA-specific IgM, IgG1, IgG2a
and total IgE antibodies in serum was determined by
ELISA as previously described.17
LUNG HISTOLOGY
The mice were sacrificed by asphyxiation at 48 hours
after the last OVA challenge, and lungs were infused
with 10% (vv) formalin in PBS buffer for fixation.
The lung samples were sectioned, stained with hema-
toxylin and eosin (H&E) reagents or with periodic
acid-Schiff (PAS) reagent, and examined for patho-
logical changes under a light microscope at ×100
magnification. The number of infiltrated mononuclear
cells in the peribronchiolar regions was calculated by
direct counting in four different fields per slide.
QUANTITATIVE PCR ANALYSIS
Total RNA was isolated from lungs (3 mice in each
group) using the TRIzol reagent (SIGMA-Aldrich, St.
Louis, USA). Reverse transcription was carried out
with Superscript II RT (Invitrogen, Carlsbad, USA).
The samples were then subjected to real-time PCR
analysis on an ABI PRISM 7300 Sequence Detection
System (Applied Biosystems, Foster City, USA) using
standard conditions. The primers and the TaqMan
probes for the detection of Muc5ac, gob-5, and hprt
were purchased from Applied Biosystems. The ex-
pression of mRNA was normalized using the hprt sig-
nal.
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CELL PREPARATION AND THE MEASUREMENT
OF CYTOKINES
The mice treated with or without NGC were sacri-
ficed after OVA inhalation. The single-cell suspen-
sions of the spleen cells were prepared in RPMI 1640
medium. Splenic CD4 T cells were purified by mag-
netic beads and an Auto-Macs Sorter (Miltenyi
Biotech, Gladbach, Germany). The purity of CD4 T
cells was >90%. We thereafter cultured CD4 T cell
(4 × 105) and irradiated (3000 rad) normal BALBc
splenocytes (1 × 106) with OVA (100 μgmL) for indi-
cated hours. The supernatants were collected three
or four days later. The concentrations of IL-2, IL-4, IL-
5, IL-13, and IFN-γ were measured by ELISA as de-
scribed previously.18
DATA ANALYSIS
The statistical analysis was performed using the two-
tailed Student’s t-test. All values are expressed as the
mean ± standard deviation (SD).
RESULTS
NGC PREPARED FROM THE TOMATO EXTRACT
REDUCES EOSINOPHILIC INFILTRATION IN THE
BAL FLUID AND THE AHR
The aim of this study was to examine the effect of
oral administration of NGC on allergic asthma. In or-
der to induce the allergic asthma, the mice were sen-
sitized with OVA-alum on days 0 and 7, and then chal-
lenged with aerosolized OVA on days 21 and 23. The
NGC was orally administered every day until the day
of sacrifice. Firstly, the development of AHR was ex-
amined by measuring the methacholine induced air-
flow obstruction using a mechanical ventilator (Fig. 1
A). The extent of AHR in the mice that were treated
with NGC was attenuated in comparison with the pla-
cebo control group. At this time, the BAL fluid was
harvested and examined for the infiltration of the in-
flammatory cells (Fig. 1B). The absolute numbers of
eosinophils, neutrophils, lymphocytes and macro-
phages were determined based on the morphological
criteria. As shown in Figure 1B, total cell numbers of
the infiltrating leukocyte decreased significantly in
the NGC-treated mice. A significant decrease in the
absolute number of eosinophils was also observed.
The results suggest that the OVA-induced AHR and
the airway inflammation were attenuated by the oral
administration of NGC. We also measured antibody
titers in the serum of these mice one day after the last
inhalation. The concentration of OVA-specific IgM,
IgG1 and IgG2a and total IgE in the serum of NGC-
treated mice was comparable to that of placebo con-
trol mice (Fig. 1C).
HISTOLOGICAL ANALYSIS OF LUNGS FROM
THE NGC-TREATED MICE
The histological changes in the lungs of OVA-
sensitized and OVA-challenged NGC-treated mice
were examined. An inflammatory cell infiltration was
not found in the lungs of the mice that did not receive
either the OVA sensitization or the challenge (Fig. 2
A, No treat). After the OVA challenge, a substantial
number of mononuclear cells were infiltrated in the
peribronchiolar regions in the OVA-sensitized mice
treated with placebo (Fig. 2A, Placebo). The infiltra-
tion was moderate in the mice that received NGC in
comparison with the mice that were on placebo (Fig.
2A, NGC). The number of the infiltrated mononu-
clear cells was assessed semi-quantitatively, and de-
creased in the NGC-treated mice (Fig. 2B).
We then examined the levels of mucus hyper-
production by PAS staining. The representative stain-
ing profiles of the bronchiolar region of the asthmatic
lung are shown in Figure 2C. A specific staining was
not detected in the mice that did not receive the OVA-
sensitization and the OVA-challenge (Fig. 2C, No
treat). A strong PAS staining was found in the bron-
chioles of the asthmatic lung of the mice treated with
the placebo, whereas the staining levels appeared to
be lower in the mice treated with NGC (Figure 2C,
comparing placebo and NGC). Consequently, we ex-
amined the expression of Muc5ac and gob-5, and
slightly decreased expression was found in the lungs
of the NGC-treated mice (Fig. 2D). These results sug-
gested that the level of mucus hyperproduction was
reduced moderately after the oral administration of
NGC.
NGC REDUCES TH2 CYTOKINE PRODUCTION
FROM SPLENIC CD4 T CELLS
In order to assess the effect of NGC on the effector
function of the CD4 T cells, cytokine production in
the splenic CD4 T cells from NGC-treated mice was
examined (Fig. 3). The splenic CD4 T cells were puri-
fied from the OVA-sensitized and -challenged mice
treated with or without NGC, and were stimulated
subsequently with OVA and irradiated APCs in vitro.
Three and four days later, culture supernatants were
collected, and the concentration of cytokines (IL-4,
IL-5, IL-13, IFN-γ and IL-2) were determined by
ELISA. The production of IL-4, IL-5, and IL-13 was
lower in the mice treated with NGC in comparison
with the mice treated with placebo. In contrast, the
levels of IL-2 and IFN-γ were comparable. These re-
sults indicate that the oral administration of NGC re-
sulted in reduced Th2 cytokine production from CD4
T cells of the spleen.
DISCUSSION
The administration of tomato extract has been re-
ported to improve perennial allergic rhinitis in hu-
mans.12 In this report, we used NGC that was purified
from the skin of red tomatoes, and demonstrated that
the oral administration of NGC suppressed airway in-
flammation and the AHR in a mouse allergic asthma
model. NGC appears to suppress the Th2-dependent
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Fig. 1 Reduced airway hyperesponsiveness (AHR) and airway inflammation in NGC-treated mice. 
AHR and airway inflammation were induced with OVA-sensitization and OVA-chalenge in the mice 
treated with or without NGC. (A) One day after the last OVA chalenge, AHR in response to increasing 
doses of methacholine was assessed by measuring lung resistance. (B) The absolute numbers of eosino-
phils (Eos.), neutrophils (Neut.), lymphocytes (Lym.) and macrophages (Mac.) in the BAL fluid are shown. 
The results were obtained using the values from cel counting, the percentages of the cels, the total cel 
number per mililiter, and the volume of BAL fluid recovered. The samples were colected 24 hours after 
the last OVA chalenge. (C) The levels of total IgE and OVA-specific IgG1, OVA-specific IgG2a and OVA-
specific IgM in the serum were determined by ELISA. The samples were colected 24 hours after the last 
OVA chalenge. Four independent experiments were done with similar results. Five animals from each 
group were individualy examined, and the mean values with their SD are indicated. The diferences were 
statisticaly significant between the mice treated with placebo and the mice treated with NGC (*p < 0.05, 
and **p < 0.01).
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airway inflammatory responses via the inhibition of
the Th2 cytokine production from CD4 T cells of the
spleen.
Naïve CD4 T cells differentiate into effector T cells
upon stimulation by antigen. The cytokines present
in the environment of the antigen- recognition by T
cell receptor on CD4 T cells determine which effector
T cells are induced such as Th1, Th2 or Th17 cells.19
In this OVA induced-allergic airway inflammation
model, Th2 cells are induced by sensitization with
OVA and Alum injection.20 We examined the cy-
tokine production of CD4 T cells in the NGC-treated
mice. As a result, the Th2 cytokine production in CD4
T cells of the NGC-treated mice was lower than that
of placebo-treated mice (Fig. 3). We investigated the
proliferation of CD4 T cells from the NGC-treated or
untreated mice by measuring thymidine-uptake, and
found that there were no significant differences in
proliferative responses (data not shown). These re-
sults suggest that NGC suppresses the Th2 cytokine
production from CD4 T cells without affecting the
proliferative ability of CD4 T cells.
Late phase allergic responses in the airway are in-
duced by Th2 cells and by eosinophills that infiltrate
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Fig. 2 Reduced leukocyte infiltration into the lungs and mucus production in NGC-treated mice. The levels of OVA-
induced airway inflammation and mucus production in the mice treated with NGC were examined by histological 
analysis and quantitative real-time RT-PCR. (A) Antigen-induced leukocyte infiltration into the lungs was evaluated 
using hematoxylin and eosin (H&E) staining. (B) The number of infiltrated mononuclear cels in the perivascular and 
peribronchiolar regions was calculated by direct counting from four diferent fields per slide. The diferences were sta-
tisticaly significant between the mice treated with placebo and the mice treated with NGC (*p < 0.05). (C) Antigen-in-
duced goblet cel hyperplasia was evaluated by PAS staining. The representative photographic views of the mice 
treated with or without NGC are shown. (D) The total mRNA was prepared from the lung of the mice treated with or 
without NGC, and the mRNA levels of Muc5ac and gob-5 were examined. The data represent the mean values of 
Muc5ac and gob-5 mRNA expression normalized with hprt expression. The mean values with the standard deviation 
(n = 5) are shown. Three independent experiments were performed with similar results.
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in the lung from 2 to 6 hours after antigen exposure.6
In this study, NGC administration inhibited the pro-
duction of IL-4, IL-5 and IL-13 from CD4 T cells. IL-13
is known to induce AHR in the absence of inflamma-
tory cells.21 IL-13 and IL-4 also play an important role
in the production of mucus.5 These symptoms are
characteristic of asthma, and are linked to asthma fa-
tality. IL-5 is known to activate and enhance the sur-
vival of eosinophils.22 Regarding the proteins present
in eosinophils, the most prominent granule protein is
a cationic heme-containing protein known as eosino-
phil peroxidase (EPO). The second is the major basic
protein (MBP), which is also released during eosino-
phil degranulation. Although these eosinophil gran-
ules induce cytotoxicity in lung tissue such as airway
epithelial cells, it has also been reported that EPO
and MBP do not contribute to allergen-induced air-
way pathogenesis in mice.23,24 In any event, the re-
duction of Th2 cytokine production from CD4 T cells
may result in attenuated eosinophillic inflammation
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Fig. 3 Reduced Th2 cytokine production from splenic CD4 T cels in mice treated with 
NGC. Splenic CD4 T cels from the NGC-treated mice or the placebo-treated mice were 
prepared and stimulated subsequently in vitro with OVA and APCs. The culture super-
natants were colected 72 and 96 hours later. The mean values with standard deviation are 
shown (n = 5). Three independent experiments were performed with similar results. The dif-
ferences were statisticaly significant between the mice treated with placebo and the mice 
treated with NGC. N.D., not detectable.
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and AHR in NGC-treated mice.
IgE and mast cells play a crucial role in the induc-
tion of acute phase allergic responses that occur im-
mediately after antigen exposure.6 The levels of IgE
were unchanged by treatment with NGC (Fig. 1C). It
is well established that IL-4 is produced by Th2 cells.
However, there are other pathways which induce IgE
production in allergic inflammation. IL-4 and IL-13 are
secreted not only by CD4 T cells but also by mast
cells, and IL-4 from mast cells influences the produc-
tion of IgE from B cells.25 In addition, soluble CD23
regulates the production of IgE from B cells.26,27
NGC may not suppress the production of IgE
through these pathways, although the reduction of
Th2 cytokines from CD4 T cells was detected. We
have not detected any defects in B cell function in
mice with NCG administration (unpublished observa-
tion).
We previously reported that NGC inhibits hista-
mine release from mast cells.10 Therefore, although
NGC treatment did not inhibit IgE production, NGC
could suppress the type I allergic reaction by inhibit-
ing the release of histamine from mast cells. The
mechanisms by which NGC suppresses Th2 cytokine
production of CD4 T cells and deregulation from
mast cells are not clearly understood. Tan et al. re-
ported that trans-Resveratol, a polyphenol of red
wine, inhibited human eosinophil activation and de-
regulation via inhibition of activation of p38 and ERK
12.28 Therefore, NGC is a polyphenol from tomatoes
and it may inhibit some signaling molecules in CD4 T
cell and mast cells. Further investigation is required
to elucidate the mechanism by which NGC reduces
the Th2 cytokine production from CD4 T cells or the
release of chemical mediators from mast cells.
We administered 0.8 mgkgday NGC. NGC is
contained in tomato cultivar for processing or cherry to-
mato but not in a commonly consumed tomato in Ja-
pan. Fifteen cherry tomatoes contain approximately
0.8 mg NGC, and thus the amount of NGC which is
taken by a mouse (20 g) per day is equivalent to 0.3
of the amount contained in one cherry tomato. Hu-
mans (60 kg) may therefore need to eat 900 cherry
tomatoes every day for 3 weeks to consume the nec-
essary amount. As a result, we need to purify NGC
from tomatoes and provide it as a supplement for
practical administration.
In conclusion, the oral administration of NGC was
shown to suppress Th2 cytokine production from
CD4 T cells in the spleen and to attenuate allergic air-
way inflammation and AHR. The high-dose, long-term
oral administration of the tomato extract containing
NGC did not show any severe adverse events.29
Therefore, taking NGC as a supplement may be bene-
ficial to patients with allergies.
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